Study Stopped
Sponsor decision to terminate.
NeuroPath Comparative Validation Study Plan
1 other identifier
interventional
200
1 country
2
Brief Summary
The purpose of the study is to compare the performance of the NeuroPath automated nerve conduction test with the standard of care manual test in the diagnosis of entrapment neuropathies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Aug 2006
Shorter than P25 for phase_3
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2006
CompletedFirst Submitted
Initial submission to the registry
October 27, 2006
CompletedFirst Posted
Study publicly available on registry
October 30, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2006
CompletedJune 6, 2007
June 1, 2007
October 27, 2006
June 5, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Validity of the NeuroPath
Secondary Outcomes (1)
Accuracy of the NeuroPath
Interventions
Eligibility Criteria
You may qualify if:
- Sensory symptoms (numbness and/or tingling) aggravated by at least 1 of the following: sleep, sustained hand or arm positioning, or repetitive actions of the hand.
- Sensory symptoms (numbness and/or tingling) mitigated by at least 1 of the following: changes in hand posture, shaking the hand, or use of a wrist splint.
- If pain is present, the wrist, hand, and finger pain is greater than elbow, shoulder, or neck pain if there is pain in any or all of those locations.
You may not qualify if:
- Sensory symptoms exclusive or predominatly in the little finger (D5) (ulnar neuropathy).
- Neck pain or shoulder pain preceded the paresthesia in the digits (cervical radiculopathy and/or brachial plexopathy).
- Numbness and/or tingling in the feet that preceded or accompanied the sensory symptoms in the hands (polyneuropathy).
- Medical history and physical examination that indicates an explanation for the sensory symptoms which is more probable than CTS. For example, digital neuropathy, median nerve pathology proximal to the carpal tunnel, ulnar neuropathy, radical neuropathy, brachial plexopathy, cervical radiculopathy, spinal cord, brainstem or brain pathology, or a polyneuropathy.
- Absence of 1st, 3rd, 4th or 5th digits
- Open wounds at the measurement sites
- Excessive sensitivity to electrical stimulation
- Median nerve injection in the past 30 days
- Prior carpal tunnel surgery
- Patients who are susceptible to radio frequency noise - such as patients with pacemakers or patients that have electrical stimulators of any sort.
- Normal neurological examination
- Absence of 1st, 3rd or 5th digits
- Open wounds at the measurement sites
- Excessive sensitivity to electrical stimulation
- Median nerve injection in the past 30 days
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Excel-Tech Ltd.lead
Study Sites (2)
Harmonex Neuroscience Research
Dothan, Alabama, 36303, United States
SunCoast Neuroscience Associateion
St. Petersburg, Florida, 33701, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ron Kurtz
Excel-Tech Ltd. (XLTEK)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
October 27, 2006
First Posted
October 30, 2006
Study Start
August 1, 2006
Study Completion
December 1, 2006
Last Updated
June 6, 2007
Record last verified: 2007-06